Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025

Fireside chat with Chairman & CEO Lishan Aklog, M.D., scheduled for Friday, September 5, at 8:35 AM EDTNEW YORK, Aug. 27, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM) ("PAVmed"), today announced Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 in New York, NY ...